A B S T R A C T The role of liver in the peripheral conversion of thyroxine (T4) to triiodothyronine (Ts) was studied in normal subjects and patients with alcoholic liver disease by measurement of thyrotrophin (TSH) and total and free T4 and T3 in random and serial serum samples. Also, T4 to Ts conversion rates and Ts disposal rates were compared by noncompartmental analysis. While the mean total serum T4 values were similar for the two groups, 8.6 and 8.1 ug/dl, the mean free To value was significantly higher in the cirrhotic patients (3.3 ng/dl) than in the normal subjects (2.1 ng/dl, P < 0.001). The mean serum T3 value, 85 ng/dl, was significantly reduced in the hepatic patients as compared to a mean serum T8 value of 126 ng/dl in the normal subjects (P < 0.001), while the free T3 value was 0.28 ng/dl in both groups. The reduction of the serum total and free Ts values were closely correlated with the degree of liver damage, as indicated by elevation of serum bilirubin (r = -0.547) and reduction of serum albumin (r = 0.471). The mean serum TSH level was 3.1 AiU/ml in the normals and 7.1 tU/ ml in the cirrhotic patients (P < 0.001). 15% of the hepatic patients had serum TSH values above 10 AU/ ml, which, however, did not correlate with any of the four liver function tests studied. Serial blood sampling from two convalescing patients with alcoholic hepatitis showed a gradual normalization of serum TSH and Ts levels as the liver function improved. After oral T4 administration, 0.25 mg/day for 10 days, three of four cirrhotic patients studied failed to raise their serum Ts values. The mean T4 to Ts conversion rate of seven normal subjects was 35.7%. The mean T4 to T3 conversion rate of four cirrhotic patients studied was significantly reduced to 15.6% (P < 0.001). The mean Received for publication 12 March 1974 and in revised form 22 May 1975. disposal rates of T4 and T3 of the normal subjects were 114 and 34 ,ig/day, respectively. The ratio of T, disposal to T3 disposal was 3.5. In contrast, the mean T4 disposal rate, 82 Ag/day, and the mean Ts disposal rate, 10 ug/day, were both reduced in the cirrhotic patients. Their ratio of T4 disposal to Ts disposal was 7.9. These findings suggest that impairment of T4 conversion in patients with advanced hepatic cirrhosis may lead to reduced Ts production and lowered serum Ts level. Therefore, the liver is one of the major sites of T4 conversion to Ts.
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INTRODUCTION
It is now well established that thyroxine (T4) ' is converted to triiodothyronine (T3) in the peripheral tissues of man (1) (2) (3) (4) , rat (5) , and sheep (6) . The contribution of this pathway to the total Ts production appears to be higher in man and sheep than in rat. T3 can also be converted from T4 in vitro by perfused rabbit liver (7) and rat heart (8) , by slices of pituitary (9) , kidney (10) , and brain (11) , and by tissue cultures of human fibroblast (12) , kidney, and liver (13) . Still, it is not known in what proportion the different organs contribute to the overall T3 production in the intact animal under physiological circumstances. Several early studies suggest that liver plays a role in the metabolism of thyroid hormones (13) (14) (15) (16) (17) (18) (19) (20) . Cavalieri and Searle (17) estimated the hepatic volume of distribution for To to be approximately 38% of the total T4 volume of distribution. More recently, another laboratory as well as our own reported the observation of reduced Ts and elevated thyrotropin (TSH) levels in the serum of /Agg/100 ml ,/U/mi TSH FIGURE 1 Random serum T4, T8, and TSH were assayed by radioimmunoassay in normal subjects and hepatic patients. The range of values obtained from normal subjects is shown as shaded area. The individual values from the liver patients are shown as dots while the group mean is shown as a horizontal bar.
hepatic patients (21, 22 ) that suggested possible failure of To conversion. The present study was carried out to define the role of liver in the peripheral conversion of T4 to Ts. Random and serial serum samples from normal subjects and hepatic patients were assayed for TSH, and total and free T4 and Ts. The T4 to Ts conversion rate and the T4 and Ts disposal rates were estimated in both normal subjects and cirrhotic patients by noncompartmental analysis and were found to be markedly reduced in the cirrhotic patients. The results of these studies constitute the substance of the following report.
METHODS
Subjects. Normal volunteers were selected from the medical personnel for their good general health and absence of any thyroid or liver disorder. The hepatic patients were chosen from the hospitalized patients of two urban hospitals for advanced alcoholic liver disease, as documented by different combinations of hepatomegaly, icterus, ascites, abnormal serum proteins, and elevated bilirubin, alkaline phosphatase, and transaminase levels. The serum bilirubin, transaminase, and alkaline phosphatase were measured by AutoAnalyzer (Technicon Instruments Corporation, Ardsley, N. Y.) and the serum albumin was measured by electrophoresis in the hospital laboratories. Among the etiologies of the liver disorder were alcoholic cirrhosis, alcoholic hepatitis, and acute viral hepatitis. All subjects had given their informed consent for the present study.
Hormone assays. Serum TSH (23), T4 (24) , and T8 (25) were assayed by the double-antibody technique of radioimmunoassay. Serum free T4 and free T8 were measured by dialysis, simultaneously, according to the method of Sterling and Brenner (26) with minor modifications. Human pituitary TSH standard 68/38 was a gift from the National Institute for Medical Research (Mill Hill, London). The purified human TSH for iodination was provided by the National Institute of Arthritis, Metabolism and Digestive Diseases (Bethesda, Md.). The T4 and Ts standards were purchased from Sigma Chemical Co. (St. Louis, Mo.). The anti-T4 antiserum and the anti-Ts antiserum were raised in our laboratory in rabbits immunized with bovine albumin conjugate of T4 or T8. The final dilution of anti-T, antiserum was 1: 2,500 and that of anti-T8 antiserum was 1:12,000. An anti-rabbit gammaglobulin antiserum from goat was used as the second antibody and was purchased from Antibodies, Inc. (Davis, Calif.). The interassay coefficients of variation for TSH, T4, and T8 assays were 7.9, 3.4, and 7.9%o, respectively. The intraassay coefficients of variation was 2.2% for TSH, 4.1%o for T4, and 3.9%o for Ts. Each sample was run in triplicate. The random serum samples from normal subjects and hepatic patients were randomized and assayed together. In the longitudinal studies all sera from the same subject were assayed together. The least detectable concentration in the TSH assay varied between 1.5 to 2.1 ,/U/ml, calculated as the mean minus two standard deviations of the zero tube. Subjects with undetectable TSH level were routinely assigned a level half the respective least detectable concentration for the calculation of means. For the present study, no normal control had an undetectable TSH level.
Kinetic analysis. Radiothyroxine labeled with 'I and radiotriiodothyronine labeled with 'I, with a specific activity over 40 gGCi/,g and 50 /sCi//sg, respectively, were purchased from Amersham-Searle Corp. (Arlington Heights, Ill.). The purity of the radioactive hormones was 95-97%, as monitored by paper chromatography. They were diluted to the desired concentration with a 1% human albumin solution in normal saline and then passed through a Millipore filter (Swinnex 0.22 ttm, Millipore Corp., Bedford, Mass.). The radioisotopes were assayed simultaneously in a well scintillation counter with a two-channel analyzer. The assay of 'I activity was corrected for 'I spillage.
The subjects were given T4 by mouth, 0.25 mg daily, starting at least 2 wk before and 5 drops three times a day of Lugol's solution, starting just before study. At the start of study, the patients were given an intravenous injection of a combined dose of 60,Ci of 'I-labeled T4 and 100 /LCi of 'I-labeled T8 in 1%7o sterile human albumin solution. Blood samples were taken at 0, 0.15, 1, and 2 h and then at 4-h intervals during the first 48 h and then at daily intervals up to 14 days. The serum was separated and an aliquot was stored at -20'C for radioimmunoassays later. The remaining aliquot was treated with propylthiouracil and sodium iodide, and precipitated with trichloroacetic acid as described elsewhere (3). The precipitate was extracted three times with three volumes of ethanol. The difference of radioactivity between the total precipitate and the extracted precipitate was assumed to represent the hormonal activity. The dose standard was added into the zero-time serum sample of each subject precipitated and extracted similarly. The recovery of radioactive T4 and Ts was 90%o and 85%, respectively.
Calculation. The serum radioactivity (percentage of dose per liter) was plotted as a function of time.
The metabolic clearance rate, T4 and Ts disposal rates, and the conversion rate of T4 to T8 were estimated by the noncompartmental method of Tait (27) with minor modifications (28 remainder presented with acute alcoholic hepatitis and/or alcoholic cirrhosis. Alcohol intoxication was absent at the time of blood sampling. The results from these two groups are compared in Fig. 1 and the clinical information of the hepatic patients is tabulated in Table I . The data of two hepatic patients were deleted from the calculation of group means. One of these patients, P. W., No. 6, was considered to lhave primary hypothyroidism besides his liver disorder. The other patient, J. P., No. 4, had a history of Graves' disease for which he had received 'I therapy 6 yr before. The recovery of unlabeled T8 added to a pool of serum from patients with liver disease did not differ from the recovery data of a pool of normal serum, in agreement with the observation by Chopra, Solomon, Chopra, Young, and Chua Teco (21) . Bilirubin added into the assay tubes up to 100 mg/dl did not shift the curve of TSH standard.
The studies of patients with alcoholic liver disease are shown in Table II . The mean levels of serum total and free T4 of the normal subjects were 8.6±+1.7 /hg/dl and 2.1+0.3 ng/dl, respectively. The mean levels of the total and free serum T4 of the hepatic patients were 8.1±2.7 ,ug/dl and 3.3±0.9 ng/dl, respectively.
There was no difference between the mean total serum To levels, while the mean free serum To level of the hepatic patients was significantly higher than that of the normal subjects (P < 0.001).
The mean serum T8 concentration of the normal controls was 126+23 ng/dl. The mean serum Ts concentration of the hepatic patients was 85±50 ng/dl. The difference between the Ts levels of these two groups was statistically significant (P < 0.001). 21 of the patients had To levels below the range of normal controls and many had Ts values low enough to be compatible with advanced hypothyroidism. The serum free T8 fraction was high, so the serum free Ts was low in the patients with low serum total Ts and high in the patients with normal levels of serum total Ts. The mean serum free Ts level was the same for both groups (0.27 and 0.28 ng/dl). The reduction of serum T3 in the hepatic patients was proportionately greater than the reduction of their serum T4 values. The mean total T4/total T8 ratio of the normal controls was 62 +9, whereas that of the liver patients was nearly (louble(l, 117+52 (P < 0.05). A similarly significant difference between the free T,/free Ts ratios of the normal controls (7.5) and the hepatic patients (14.4) was observed. The reduction of serum total and free Ts levels was poorly correlated with the levels of serum transaminase or alkaline phosphatase (Table III) . However, it showed a positive correlation with the serum albumin concentration (r = 0.471) and a negative correlation with the serum bilirubin concentration (r = -0.547). Therefore, the alteration of serum Ts level more closely reflected the synthetic capacity of the liver than its cellular integrity.
The mean serum TSH level of the normal subjects was 3.1±0.6 AU/ml. normal controls, they appeared to have higher values of serum total and free T4 as well as higher values of serum TSH (Table IV) . Their ratios of total T4 to total Ts (88+21) and free T4 to free Ta (12+4) suggest that the patients with acute viral hepatitis also have lowered serum Ts levels relative to the levels of serum T4.
A longitudinal study of liver function, serum TSH, T4, and Ts was carried out in two hepatic patients with moderately severe alcoholic hepatitis. The results of these patients were similar and one of these studies is depicted in Fig. 2 . The results demonstrated that the alterations of serum TSH and Ts were transient and reversible in acute hepatic disease. Upon improvement of the liver function, serum TSH and Ts also showed a tendency to normalize in accord with the reversible liver damage.
Another group of seven normal medical personnel and four patients with advanced but stable liver cirrhosis, and without clinical ascites, were included for the study to estimate the extrathyroidal T4 conversion rate to Ts. Each subject was given T4, 0.25 mg/day, by mouth starting 2 wk before the kinetic study to suppress the thyroidal secretion of T14 and Ts. TSH, T4, and Ts levels in these subjects were followed during the first 10 days. The mean serum TSH of the normal subjects was 4.8±2.4 AU/ml at the start and 4.5±2. 4 AU/ml at the end of study. Reduced Triiodothyronine Production in Hepatic Cirrhosis
rates 10.0-25.1%, with a mean 15.6±6.6% (P < 0.005).
In the normal subjects the estimated disposal rates of T4 and Ta were 114+20 jug/day and 34±7 jug/day, respectively, with a T4 disposal to T3 disposal ratio of 3.5. In the hepatic patients the disposal rate of T4 was found to be low, 82±25 jig/day, which suggests impairment of T4 absorption in some of the patients. The T4 tablets were given by the nursing staff to both groups, and the patients did not have other symptoms of malabsorption. The mean Ta disposal rate in the cirrhotic patients was reduced to 10±3 jug/day with a T4 disposal/T3 disposal of 8.2, suggestive of a 70% decrease of Ta production by T4 deiodination. These findings suggest a significant impairment of peripheral T4 conversion to T3 in patients with advanced liver cirrhosis that leads to reduced serum Ta level.
DISCUSSION
The production of Ts is now believed to come from both thyroidal secretion and peripheral thyroxine conversion (1-4). The kinetic data of normal subjects obtained from the present study showed a much larger fraction of the extrathyroidal T3 pool (46±9%) derived from T4 conversion than that reported in our earlier study (31%) (3) . Due to methodologic difficulty in the competitive protein-binding assay of T3, the serum T3 level reported in our earlier study (3) was approximately twice our current serum T3 level for normal subjects, determined by radioimmunoassay. Radioimmunoassay of the same serum samples used in our earlier study (3) would modify our original conclusion and allow that approximately 62% of the total extrathyroidal pool of Ta or 82% of the daily T. production was derived from T4 conversion in subjects with normal thyroid function. Similar estimates were reported by other investigators using radioimmunoassay for Ta measurements (4, 5) . Our present study employed a different experimental design and a different method of calculation from our earlier study (3) . Yet the T4 to T3 conversion rate estimated by the present study was 36%, similar to the estimate of 33% reported in our earlier study (3) and close to the estimate of 42% reported by Surks, Schadlow, Stock, and Oppenheimer (28) . Such agreement between different methods and different laboratories lends support to the validity of our present method of calculation and to the conclusion of our present study, that the T4 to T3 conversion rate in the hepatic patients is reduced despite the fact that only a small number of liver patients were studied in the present report.
As compared to the average values of normal subjects, these cirrhotic patients had a 50% reduction in their mean T4 to T3 conversion rate and 70% reduction in their mean T3 disposal rate. The kinetic study of hepatic patients reported by Inada and Sterling (18) did not include the kinetics of T3. The present study agrees with their conclusion that the hepatic patients have essentially normal T4 disappearance rates, but our estimation of the T4 disposal rate was slightly lower than that of normal controls. In another kinetic study of the hepatic patients, McConnon, Row, and Volpe reported reduced T4 production, normal serum total T3 level, and elevated serum free Ta level and T3 production (29) . These results are difficult to reconcile with the findings of other investigators (18, 21) , as well as with our own observation (22) , and underline the importance of proper staging and grouping of hepatic patients. McConnon and colleagues also used a competitive protein-binding technique now believed to overestimate serum T3 levels.
Alteration in serum proteins is one of the criteria commonly used in assessing the synthetic capacity in cirrhotic patients. In the serum of hepatic patients, the level of thyroxine-binding prealbumin was reported to be reduced (18, 20) . The mean level of thyroxinebinding globulin was found to be normal, but there was wide variability of individual values. In the present study, the mean serum total T4 was unchanged, but the mean values of both the serum free T4 fraction and the actual serum free T4 were elevated in the hepatic patients. At the same time, the mean serum total T3 was reduced in the same group. The mean serum free T3 fraction was elevated so that the actual serum free T3 was low only in the patients with reduced serum total Ts, and it was elevated or normal in the patients who have normal values of serum total T3.
The resultant mean serum free Ts of the hepatic patients was in the same range as that of the normal controls. The changes in the serum total and free T3 were correlated with the severity of liver cirrhosis as reflected by the elevation of serum bilirubin and the reduction of serum albumin. Other investigators also reported elevated concentrations of serum free To (18, 21, 29) associated with reduced concentrations of serum free Ts (21) in hepatic patients. These findings cannot be explained by alteration of binding proteins alone. Rather, they suggest augmented thyroidal secretion in response to reduced circulating Ts. The synthesis of T4 is more active than the synthesis of T3 in the thyroid (30) . Therefore, the hepatic patients whose Ts production is reduced due to impaired peripheral T4 conversion to Ts, can compensate and maintain a normal serum concentration of T4 more efficiently than a normal serum Ts concentration.
Clinical signs of hypothyroidism develop after a prolonged period of thyroid hormone depletion. Our patients probably did not have Ts depletion long enough to become myxedematous although many of them had biochemical hypothyroidism. In the two patients with acute alcoholic hepatitis, the serum Ts and TSH levels appeared to parallel and normalize as the liver function improved. Also as a group, the hepatic patients showed a higher mean serum TSH level as compared to the normal controls. However, some of the hepatic patients did not show a significant rise of their serum TSH despite reduced serum total T3 and free Ts. The level of serum TSH in these patients was not correlated with either serum free T4, serum free Ts, or the ratio of the two. Nor was it correlated with the results of liver function tests. This puzzling finding is similar to the experience of Chopra and colleagues (21) . Recently, reduced serum T3 level was observed in patients with a wide variety of other illnesses (31) (32) (33) (34) and caloric deprivation (35) in whom the serum Ts level was low and the serum TSH level was in the normal range. The elevation of serum TSH value was reported only in patients with advanced liver disease (21, 22) or renal disease (34) . Some of the patients with these disorders were found to have elevated serum free To (18, 21, 31, 33) and tissue T4 concentration (31) . It is possible that T3 is not the sole biologically active thyroid hormone. The presence of elevated serum and tissue T4 concentrations is sufficient to keep the patients in an euthyroid state and the basal serum TSH level in the normal range. Most of these patients reported are said to be clinically euthyroid (21 Among the variety of illnesses associated with reduced serum T3 level are disorders of the cardiovascular and pulmonary systems, of liver and kidney, neoplasm, and caloric deprivation (21, 22, 31, 35) . The relationship between T3 metabolism and most of these disorders is not explained by our present knowledge. Not uncommonly, the liver patients also may have malnutrition and weight loss. However, a cause and effect relationship may be postulated between liver injury and abnormal T4 and Ts metabolism. In in vitro experimentation, perfused liver and liver tissue culture were shown to convert T4 to Ts (7, 13) . Reduced serum Ts values (21, 22) were associated with liver cirrhosis and alcoholic hepatitis. The cellular damage of alcoholic hepatitis and cirrhosis was shown to be uniform and diffuse (36) . In patients with advanced alcoholic cirrhosis, both the T4 to T3 conversion rate and the T4 disposal/Ts disposal ratio were significantly reduced. Supplementary To fed to these patients failed to normalize the serum T3 level. To the extent as the acute liver injury from alcoholic hepatitis was reversible, the alterations in the serum level of T8 was also reversible. Therefore, our findings are compatible with the postulate that liver may be a major site of the peripheral T4 conversion to T3 and extensive liver injury may significantly reduce To conversion to Ts and circulating T3 level.
